Kornitzer Capital Management’s Medicines Co MDCO Stock Holding History

Kornitzer Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-933,610	Closed	-$35.2M	–	489
2016 Q3	$35.2M	Sell	933,610 -205,015	-18%	-$7.73M	0.63%	40
2016 Q2	$38.3M	Sell	1,138,625 -102,885	-8%	-$3.63M	0.69%	34
2016 Q1	$39.4M	Buy	1,241,510 +27,220	+2%	+$889K	0.68%	34
2015 Q4	$45.3M	Sell	1,214,290 -231,725	-16%	-$8.76M	0.74%	27
2015 Q3	$54.9M	Buy	1,446,015 +86,150	+6%	+$3.02M	0.87%	11
2015 Q2	$38.9M	Buy	1,359,865 +472,395	+53%	+$13.2M	0.53%	61
2015 Q1	$24.9M	Buy	+887,470	New	+$24.9M	0.3%	112

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Kornitzer Capital Management's MDCO Position: Q4 2016 in Review

Kornitzer Capital Management sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 933,610 shares — an estimated $35.2M sold.

Kornitzer Capital Management first reported a position in MDCO in Q1 2015 and held it in 7 quarters. The position peaked at $54.9M in Q3 2015. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

Kornitzer Capital Management reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
Kornitzer Capital Management sold 933,610 Medicines Co shares in Q4 2016, an estimated $35.2M.
Kornitzer Capital Management first reported a position in Medicines Co in Q1 2015 and held it in 7 quarters.
Kornitzer Capital Management's Medicines Co position peaked at $54.9M in Q3 2015.
195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on Kornitzer Capital Management's 13F filing for Q4 2016, filed 31 Jan 2017.